Literature DB >> 17640969

Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.

Steve D Swain1, Soo Han, Ann Harmsen, Katie Shampeny, Allen G Harmsen.   

Abstract

Improved treatment regimens have reduced fatalities from opportunistic diseases, such as Pneumocystis pneumonia, in AIDS patients. However, serious chronic conditions, including pulmonary hypertension (PH), are increasing in this group. We report here that when CD4 T cells in Pneumocystis-infected mice are temporally depleted and then allowed to return, the extended inflammation results in PH that persists after Pneumocystis is eliminated. Using this model of PH, we have found that i) the onset of PH is correlated with the return of CD4 T cells, but PH persists after CD4 levels diminish; ii) vascular remodeling accompanies PH, but whereas temporary medial hypertrophy is evident with transient PH in immunocompetent mice, persistent PH is associated with perivascular fibrosis; iii) elevated levels of the fibrotic mediator FIZZ1 are found in bronchoalveolar lavage fluid of mice with persistent PH; and iv) although Th2-related mechanisms may be involved in PH etiology, PH still occurs in interleukin-4 receptor-deficient mice under these conditions. Overall, the data presented here demonstrate that the immune response to an infectious disease pathogen, such as Pneumocystis, can, when perturbed and prolonged, lead to later development of a serious chronic condition such as PH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640969      PMCID: PMC1959506          DOI: 10.2353/ajpath.2007.070178

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia.

Authors:  K A Fagan
Journal:  J Appl Physiol (1985)       Date:  2001-06

Review 2.  The immune reconstitution inflammatory syndrome.

Authors:  Samuel A Shelburne; Richard J Hamill
Journal:  AIDS Rev       Date:  2003 Apr-Jun       Impact factor: 2.500

Review 3.  Noninfectious pulmonary complications of HIV/AIDS.

Authors:  Georgette D Kanmogne
Journal:  Curr Opin Pulm Med       Date:  2005-05       Impact factor: 3.155

Review 4.  Primary pulmonary hypertension in HIV patients: a systematic review.

Authors:  A M Pellicelli; G Barbaro; F Palmieri; E Girardi; C D'Ambrosio; A Rianda; G Barbarini; D Frigiotti; M C Borgia; N Petrosillo
Journal:  Angiology       Date:  2001-01       Impact factor: 3.619

5.  [Dynamic changes of found in inflammatory zone 1 protein and mRNA expression in the lung with experimental pulmonary fibrosis of the rat.].

Authors:  Wan-Li Ma; Hong Ye; Xiao-Nan Tao; Jian-Bao Xin
Journal:  Sheng Li Xue Bao       Date:  2005-08-25

6.  C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.

Authors:  Deborah Elstein; Amiram Nir; Marc Klutstein; Bernard Rudensky; Ari Zimran
Journal:  Blood Cells Mol Dis       Date:  2005 May-Jun       Impact factor: 3.039

7.  Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.

Authors:  Nicole N Meissner; Steve Swain; Mike Tighe; Ann Harmsen; Allen Harmsen
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

8.  FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties.

Authors:  Xingwu Teng; Dechun Li; Hunter C Champion; Roger A Johns
Journal:  Circ Res       Date:  2003-04-24       Impact factor: 17.367

9.  Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Hilario Nunes; Marc Humbert; Olivier Sitbon; Jane H Morse; Zemin Deng; James A Knowles; Catherine Le Gall; Florence Parent; Gilles Garcia; Philippe Hervé; Robyn J Barst; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2003-02-25       Impact factor: 21.405

10.  Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients.

Authors:  Franco Recusani; Angela Di Matteo; Fabiana Gambarin; Andrea D'Armini; Catherine Klersy; Carlo Campana
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

View more
  28 in total

Review 1.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension.

Authors:  M Patricia George; Hunter C Champion; Mark T Gladwin; Karen A Norris; Alison Morris
Journal:  Am J Respir Crit Care Med       Date:  2012-06-01       Impact factor: 21.405

3.  Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.

Authors:  Dan W Siemsen; Erin Dobrinen; Soo Han; Kari Chiocchi; Nicole Meissner; Steve D Swain
Journal:  Am J Pathol       Date:  2015-12-11       Impact factor: 4.307

4.  Pneumocystis workshop: 10th anniversary summary.

Authors:  James M Beck; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2009-01-23

5.  Guest editorial--novel insights into the pathology of Stachybotrys chartarum.

Authors:  Iwona Yike; Dorr Dearborn
Journal:  Mycopathologia       Date:  2011-04-20       Impact factor: 2.574

6.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

Review 7.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

8.  Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.

Authors:  Leslie Spikes; Pranjali Dalvi; Ossama Tawfik; Haihua Gu; Norbert F Voelkel; Paul Cheney; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

9.  New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis.

Authors:  Dai Kimura; Jordy Saravia; Sridhar Jaligama; Isabella McNamara; Luan D Vu; Ryan D Sullivan; Salvatore Mancarella; Dahui You; Stephania A Cormier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

10.  CD4+ T cells and IFN-γ are required for the development of Pneumocystis-associated pulmonary hypertension.

Authors:  Steve D Swain; Dan W Siemsen; Rebecca R Pullen; Soo Han
Journal:  Am J Pathol       Date:  2013-12-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.